Stella Diagnostics, Inc.
SLDX
$0.049
$0.00922.50%
OTC PK
| 03/31/2012 | 09/30/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -97.37% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -97.37% | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -96.52% | |
| SG&A Expenses | 124.22% | 26.09% | -19.98% | 81.30% | |
| Depreciation & Amortization | 0.00% | -19.88% | -19.88% | -19.88% | |
| Other Operating Expenses | 1,080.00% | 28.57% | 0.00% | -84.85% | |
| Total Operating Expenses | 110.21% | -3.37% | -35.61% | -18.39% | |
| Operating Income | -122.69% | -23.78% | -30.77% | -204.12% | |
| Income Before Tax | -120.98% | -10.10% | -332.80% | 1,264.52% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -120.98% | -10.10% | -332.80% | 1,264.52% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -120.98% | -10.10% | -332.80% | 1,264.52% | |
| EBIT | -122.69% | -23.78% | -30.77% | -204.12% | |
| EBITDA | -147.85% | -36.96% | -47.75% | -170.67% | |
| EPS Basic | -- | -- | -- | -- | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | -- | -- | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -- | -- | |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |